Jiaqing Li, Koushiki Basu, Xiaoqing Chen, Tonglei Li
{"title":"基于分子表示的量子信息流形嵌入深度学习预测血脑屏障渗透率。","authors":"Jiaqing Li, Koushiki Basu, Xiaoqing Chen, Tonglei Li","doi":"10.1021/acs.molpharmaceut.5c01196","DOIUrl":null,"url":null,"abstract":"<p><p>Neurological disorders continue to be a leading global health challenge, with the blood-brain barrier (BBB) presenting considerable obstacles to effective drug delivery for central nervous system (CNS) therapies. Accurately predicting BBB permeability is essential for the early stages of CNS drug design. This study utilizes Manifold Embedding of Molecular Surface (MEMS) as a quantum-informed molecule representation to improve log <i>BB</i> prediction using deep learning models. Employing the B3DB data set, our approach achieved competitive performance, with an average RMSE of 0.49 ± 0.06, MAE of 0.38 ± 0.05, and <i>R</i><sup>2</sup> of 0.55. The ability of MEMS to authentically encode molecular interactions facilitates a more direct modeling of log <i>BB</i> compared to traditional descriptors. Still, as expected, model performance is influenced by the size and quality of the data, exhibiting notable variability across different B3DB groups and imbalances in the distribution of the log <i>BB</i> values. Additionally, although chirality significantly influences BBB permeability, the limited stereochemical data in the data set constrain its impact. Future efforts should focus on curating high-quality, stereochemically rich measurements and addressing data imbalances to train predictive models.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Manifold Embedding of Quantum Information as Molecule Representation to Predict Blood-Brain Barrier Permeability by Deep Learning.\",\"authors\":\"Jiaqing Li, Koushiki Basu, Xiaoqing Chen, Tonglei Li\",\"doi\":\"10.1021/acs.molpharmaceut.5c01196\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Neurological disorders continue to be a leading global health challenge, with the blood-brain barrier (BBB) presenting considerable obstacles to effective drug delivery for central nervous system (CNS) therapies. Accurately predicting BBB permeability is essential for the early stages of CNS drug design. This study utilizes Manifold Embedding of Molecular Surface (MEMS) as a quantum-informed molecule representation to improve log <i>BB</i> prediction using deep learning models. Employing the B3DB data set, our approach achieved competitive performance, with an average RMSE of 0.49 ± 0.06, MAE of 0.38 ± 0.05, and <i>R</i><sup>2</sup> of 0.55. The ability of MEMS to authentically encode molecular interactions facilitates a more direct modeling of log <i>BB</i> compared to traditional descriptors. Still, as expected, model performance is influenced by the size and quality of the data, exhibiting notable variability across different B3DB groups and imbalances in the distribution of the log <i>BB</i> values. Additionally, although chirality significantly influences BBB permeability, the limited stereochemical data in the data set constrain its impact. Future efforts should focus on curating high-quality, stereochemically rich measurements and addressing data imbalances to train predictive models.</p>\",\"PeriodicalId\":52,\"journal\":{\"name\":\"Molecular Pharmaceutics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acs.molpharmaceut.5c01196\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.5c01196","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Manifold Embedding of Quantum Information as Molecule Representation to Predict Blood-Brain Barrier Permeability by Deep Learning.
Neurological disorders continue to be a leading global health challenge, with the blood-brain barrier (BBB) presenting considerable obstacles to effective drug delivery for central nervous system (CNS) therapies. Accurately predicting BBB permeability is essential for the early stages of CNS drug design. This study utilizes Manifold Embedding of Molecular Surface (MEMS) as a quantum-informed molecule representation to improve log BB prediction using deep learning models. Employing the B3DB data set, our approach achieved competitive performance, with an average RMSE of 0.49 ± 0.06, MAE of 0.38 ± 0.05, and R2 of 0.55. The ability of MEMS to authentically encode molecular interactions facilitates a more direct modeling of log BB compared to traditional descriptors. Still, as expected, model performance is influenced by the size and quality of the data, exhibiting notable variability across different B3DB groups and imbalances in the distribution of the log BB values. Additionally, although chirality significantly influences BBB permeability, the limited stereochemical data in the data set constrain its impact. Future efforts should focus on curating high-quality, stereochemically rich measurements and addressing data imbalances to train predictive models.
期刊介绍:
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.